News | May 13, 2008

ICD Lead with Hybrid Insulation Hits U.S., European Markets

May 14, 2008 - St. Jude Medical received both FDA 510(k) clearance and European CE Mark approvals of the IsoFlex Optim pacing lead, a small-diameter lead built on the IsoFlex pacing lead platform, featuring the company’s exclusive Optim insulation material.

With the addition of Optim insulation to IsoFlex leads, all St. Jude Medical pacemaker and ICD leads now are available with Optim insulation.

Optim insulation is a hybrid insulation material that blends the biostability and flexibility of high-performance silicone rubber with the strength, tear resistance and abrasion resistance of polyurethane. Silicone rubber and polyurethane are the standard lead insulation materials. This combination is designed to provide increased durability, and to improve flexibility, handling characteristics and control during implant procedures.

Currently, St. Jude Medical is tracking more than 5,000 leads with Optim insulation in its OPTIMUM (Optim Lead Insulation Material) registry. Information gathered from this registry over the last two years will be presented at Heart Rhythm 2008, to be held May 14-17, in San Francisco.

“When I use a lead with Optim insulation, I know I am providing my patients with a product that is designed to be durable,” said S. Pakarinen, M.D., from the Division of Cardiology, Helsinki University Central Hospital in Finland, who has implanted more than 500 leads with Optim insulation. “At the same time, I know I will experience excellent handling characteristics that give me more control during the implant procedure.”

In addition to Optim insulation, the IsoFlex Optim lead offers:

- A thin profile that helps to provide better access to the vein and helps preserve venous space.
- A steroid-eluting tip, designed to reduce inflammation in the cardiac tissue to promote more stable pacing thresholds (the lowest amount of energy required by the pacemaker to continue pacing the heart).
- A small tip electrode surface to help provide higher lead impedances, which can reduce energy drain and thereby help devices last longer.
- Different lead shapes for implantation in the upper or lower chambers of the heart.

The IsoFlex Optim lead can be used with pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.

For more information: www.sjm.com

Related Content

ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init